Amgen (AMGN) is getting closer to challenging the weight-loss drug duopoly of Novo Nordisk (NVO), the maker of Ozempic and Wegovy, and Eli Lilly (LLY), which produces Zepbound.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Amgen just got one step closer to bringing its monthly weight loss drug to market )
Also on site :
- Trump economic advisor confident in China trade deal conclusion on Monday
- Trump advisor expects China trade deal conclusion Monday
- China’s Exports of Rare Earths Jump Despite Shipment Controls